Amar M. Singh, Stephen Dalton  Cell Stem Cell 

Slides:



Advertisements
Similar presentations
IPSC Crowdsourcing: A Model for Obtaining Large Panels of Stem Cell Lines for Screening Mahendra Rao Cell Stem Cell Volume 13, Issue 4, Pages (October.
Advertisements

Myc Represses Primitive Endoderm Differentiation in Pluripotent Stem Cells Keriayn N. Smith, Amar M. Singh, Stephen Dalton Cell Stem Cell Volume 7, Issue.
Cancer: Inappropriate Expression of Stem Cell Programs?
FoxO: A New Addition to the ESC Cartel
How to Remake a Fibroblast into a Neural Stem Cell
Cell Cycle Rules Pluripotency
Why Myc? An Unexpected Ingredient in the Stem Cell Cocktail
F-Class Cells: New Routes and Destinations for Induced Pluripotency
Volume 9, Issue 2, Pages (August 2011)
The 3D Genome Shapes Up For Pluripotency
Noncoding RNA Landmarks of Pluripotency and Reprogramming
Christa Buecker, Niels Geijsen  Cell Stem Cell 
Pluripotency Takes Off without Blimp1
Volume 5, Issue 1, Pages (July 2009)
Screening for Novel Regulators of Embryonic Stem Cell Identity
Volume 5, Issue 2, Pages (August 2009)
Natalia J. Martinez, Richard I. Gregory  Cell Stem Cell 
Robert Passier, Christine Mummery  Cell Stem Cell 
Volume 11, Issue 2, Pages (August 2012)
Justin Brumbaugh, Konrad Hochedlinger  Cell Stem Cell 
Volume 7, Issue 6, Pages (December 2010)
Regulating Cancer Stem Cells the miR Way
Wing Y. Chang, William L. Stanford  Cell Stem Cell 
Wenlian Qiao, Peter W. Zandstra  Cell Stem Cell 
Screening for Novel Regulators of Embryonic Stem Cell Identity
Type 1 Diabetes and MicroRNA: It’s Complicated
Why Myc? An Unexpected Ingredient in the Stem Cell Cocktail
MicroRNA Regulation of Stem Cell Fate
Recreating Pluripotency?
Hakan Bagci, Amanda G. Fisher  Cell Stem Cell 
MicroRNAs in Tfh Cells: Micromanaging Inflammaging
Angela Nakauka-Ddamba, Christopher J. Lengner  Cell Stem Cell 
Arven Saunders, Jianlong Wang  Cell Stem Cell 
The Nexus of Tet1 and the Pluripotency Network
Direct Lineage Reprogramming: Strategies, Mechanisms, and Applications
Unraveling Epigenetic Regulation in Embryonic Stem Cells
Rudolf Jaenisch, Richard Young  Cell 
Pluripotent Stem Cells and Disease Modeling
Ahmed Mohyeldin, Tomás Garzón-Muvdi, Alfredo Quiñones-Hinojosa 
Order from Chaos: Single Cell Reprogramming in Two Phases
Wnt Signaling Promotes Reprogramming of Somatic Cells to Pluripotency
Powering Reprogramming with Vitamin C
MicroRNAs in a Cardiac Loop: Progenitor or Myocyte?
Molecular Control of Induced Pluripotency
Volume 132, Issue 6, Pages (March 2008)
Modeling Rett Syndrome with Stem Cells
Hematopoietic Stem Cells in Transit— Where's the Niche?
Mitotic Bookmarking: Maintaining the Stem Cell Identity during Mitosis
Volume 13, Issue 3, Pages (September 2013)
Direct Conversion Provides Old Neurons from Aged Donor’s Skin
Mark H. Chin, Matteo Pellegrini, Kathrin Plath, William E. Lowry 
Volume 7, Issue 2, Pages (August 2010)
Volume 3, Issue 3, Pages (September 2008)
Volume 11, Issue 5, Pages (November 2012)
“Transflammation”: When Innate Immunity Meets Induced Pluripotency
Oct-4: The Almighty POUripotent Regulator?
Long Noncoding RNAs in Cell-Fate Programming and Reprogramming
TGFβ and SMADs Talk to NANOG in Human Embryonic Stem Cells
Volume 4, Issue 1, Pages (January 2009)
Volume 35, Issue 6, Pages (December 2011)
Lab-Specific Gene Expression Signatures in Pluripotent Stem Cells
Tailor Made Protein Synthesis for HSCs
Genetic and Epigenetic Regulators of Pluripotency
Historical Origins of Transdifferentiation and Reprogramming
Abby Sarkar, Konrad Hochedlinger  Cell Stem Cell 
Mesp1 at the Heart of Mesoderm Lineage Specification
Volume 19, Issue 4, Pages (April 2014)
Moving Toward the Ground State
Robert Morey, Louise C. Laurent  Cell Stem Cell 
Justin Brumbaugh, Konrad Hochedlinger  Cell Stem Cell 
Presentation transcript:

The Cell Cycle and Myc Intersect with Mechanisms that Regulate Pluripotency and Reprogramming  Amar M. Singh, Stephen Dalton  Cell Stem Cell  Volume 5, Issue 2, Pages 141-149 (August 2009) DOI: 10.1016/j.stem.2009.07.003 Copyright © 2009 Elsevier Inc. Terms and Conditions

Figure 1 Cell-Cycle Structure of Human and Murine Pluripotent Cells and Fibroblasts Typical cell-cycle profiles from a range of pluripotent cell types (mESC, hESC, miPSC, hiPSC, and mEpiSC) and primary fibroblasts are depicted. Pluripotent cells spend a high proportion of time in S phase and a low proportion of time in G1 (Savatier et al., 1996; Stead et al., 2002; Fluckiger et al., 2006; Ohtsuka and Dalton, 2008; Dalton, 2009; Neganova et al., 2009; Zhang et al., 2009). MEFs and human IMR90 fibroblasts show a lower percentage of cells in S phase and an increased proportion in G1 relative to pluripotent cells. hPRCs display a cell-cycle structure intermediate between differentiated fibroblasts and pluripotent cells. The positions of G1 cells (2n DNA content), S phase cells, and G2/M cells (4n DNA content) are indicated. The y axis represents the relative number of cells, and the x axis represents the DNA content of cells, a readout for cell-cycle position. Cell Stem Cell 2009 5, 141-149DOI: (10.1016/j.stem.2009.07.003) Copyright © 2009 Elsevier Inc. Terms and Conditions

Figure 2 The Relationships between Pluripotency Regulators, Cell Cycle, and Cell Size Control The core transcriptional network (Oct4, Nanog, and Sox2), together with Myc, regulates key aspects of pluripotent cell biology, including the cell cycle and cell size. This is achieved in conjunction with the PI3K-mTOR signaling pathway and through the regulation of miRNAs. Cell Stem Cell 2009 5, 141-149DOI: (10.1016/j.stem.2009.07.003) Copyright © 2009 Elsevier Inc. Terms and Conditions

Figure 3 How Myc and Cell-Cycle-Regulatory Controls Intersect with Different Stages of Reprogramming Cells subject to reprogramming cues undergo a three-step process as they transition toward iPSCs. The initial step involves Myc, which causes global changes in genes expression, including repression of differentiation genes, without induction of pluripotency genes (see Sridharan et al., 2009; Zhao and Daley, 2008; Maherali et al., 2008; Judson et al., 2009; Silva et al., 2008; Mikkelsen et al., 2008). Other reprogramming factors, possibly in combination with Myc (Huangfu et al., 2008), then drive the formation of PRCs and then fully reprogrammed iPSCs. Roles for Myc have also been defined in the maintenance of iPSCs and other pluripotent cell types, some of which are directly related to cell-cycle control (Cartwright et al., 2005; Wang et al., 2008; Judson et al., 2009; Hanna et al., 2009). Possible points at which Myc could be involved, but for which there are no solid data, are indicated by broken arrows. For example, it is likely that cells in the process of being reprogrammed need to be constantly kept cycling by Myc. Cell Stem Cell 2009 5, 141-149DOI: (10.1016/j.stem.2009.07.003) Copyright © 2009 Elsevier Inc. Terms and Conditions